Early Stage Drug Development Company
We’re a high value-added company that applies photoisomerization conversion technology
Financial Information
Sales

Unit:1,000 KRW
Y2019 | Y2020 | Y2021 |
---|---|---|
583,912 | 544,000 | 413,942 |
Gross profit

Unit:1,000 KRW
Y2019 | Y2020 | Y2021 |
---|---|---|
496,690 | 412,861 | 413,942 |
Profit

Unit:1,000 KRW
Y2019 | Y2020 | Y2021 |
---|---|---|
156,826 | 55,034 | 67,819 |
Net Income

Unit:1,000 KRW
Y2019 | Y2020 | Y2021 |
---|---|---|
146,816 | 20,943 | 21,770 |